Implementing the New ASAM Criteria – Research, Regulations, and Resolutions
The revised 2023 Fourth Edition of The ASAM Criteria is soon to be released. This webinar will provide a high-level overview of the changes to The ASAM Criteria, how it has been adapted, and how it will be evaluated.
- Describe the major changes that will appear in The ASAM Criteria Fourth Edition.
- Describe at least three research priorities to evaluate the effectiveness of implementation for The ASAM Criteria Fourth Edition.
- Explain how lessons learned from the Third Edition implementation at the state level can help to inform states’ implementation of the Fourth Edition.
Prescribing clinicians and their teams
Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Maine Medical Education Trust and CCSME. The Maine Medical Education Trust is accredited by the Maine Medical Association Committee on Continuing Medical Education and Accreditation to provide continuing medical education for physicians.
The Maine Medical Education Trust designates this regularly scheduled series for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
1 contact hour for social workers, licensed clinical professional counselors, and behavioral health professionals.
Jeffrey GoldsmithMD, DLFAPA, DFASAM
R.Jeffrey Goldsmith MD, DLFAPA, DFASAM is a board certified Addiction Medicine subspecialist.
He was president of the American Society of Addiction Medicine 2015-2017. He ran the Addiction fellowships at the Cincinnati VA Medical Center for 20 years and was Professor of Clinical Psychiatry for the College of Medicine. Dr. Goldsmith worked clinically in the Dual Diagnosis Clinic, the Buprenorphine Treatment Clinic, and the Traumatic Brain Injury PTSD program. He was a co-investigator in the Clinical Trials Network from 1995-2008.